53 results about "Vasoconstriction" patented technology

The invention relates to the technical field of health status assessment, in particular to a cardiovascular disease layered early warning system, which is characterized in that blood vessel compliance and pulse wave velocity are extracted, arterial dilation capacity is measured, blood vessel elasticity is calculated, blood perfusion distribution is detected, and abnormal vasoconstriction is classified on the basis of a hemodynamic state and a heart electrical activity state; in combination with the thickness of the blood vessel wall and the blood vessel stenosis rate, the plaque deposition condition is analyzed, the arteriosclerosis score is calculated, the thrombosis tendency is detected, the local blood flow blocking degree is quantified, the isolation forest algorithm is adopted, the blood flow dynamic change is calculated, the heart rhythm abnormality is analyzed, the acute vascular occlusion probability is measured, and the sudden heart rhythm abnormality risk is evaluated. And based on a gradient boosting tree algorithm, screening high-risk cases, matching medical intervention measures, setting a risk buffer mechanism, adjusting an individual health management strategy, and optimizing a cardiovascular risk hierarchical early warning system.

The invention discloses a blood protein precise active peptide capable of tonifying qi and blood, improving microcirculation and promoting vasodilation and a preparation method and application thereof, and belongs to the technical field of blood protein peptide. The blood protein precision active peptide comprises at least one of LGFP, IGFP, FPHFN, LFL, LFI, FESF, ILF, LIF, FLL, FIL, FII or FPHFD. The prepared blood protein precision active peptide has multiple biological activities: an antihypertensive effect is achieved by inhibiting ACE and vasoconstriction substances; vasodilation is promoted by activating a PI3K / AKT / eNOS signal channel; a zebra fish model proves that the traditional Chinese medicine composition has the effects of remarkably improving microcirculation and tonifying qi and blood. The preparation method is low in equipment requirement, simple in process, easy to operate and convenient for industrial large-scale production. The method enriches a bioactive peptide library, and is of great significance in promoting technical progress and industrial upgrading in the field of hemoglobulin peptides.

The present invention relates to a traditional Chinese medicine composition for treating psoriasis, and its preparation method and use. The traditional Chinese medicine composition is prepared from the following raw materials: Portulaca oleracea, Sophora flavescens, Dictamni bark, Honeysuckle, Kochia scoparia, Phellodendron amurense, Platycladus orientalis leaves, Paeonia lactiflora, and Lithospermum officinale. The traditional Chinese medicine composition of the present invention has a scientific and reasonable formulation, synergistic efficacy, a small number of ingredients, and controlled quality. The combination of monarch, minister, adjuvant, and envoy in the present invention's formulation is scientific and reasonable. The combination of anti-inflammatory and immunomodulatory heat-clearing, blood-cooling, and antipruritic drugs can effectively eliminate the cause of the disease and enhance the antipruritic effect, exerting anti-inflammatory, antiproliferative, and local vasoconstrictive effects, with the advantages of increased efficacy and reduced toxicity, and can reduce the risk of recurrence. This promotes epithelial tissue repair, maintains the dynamic balance of skin keratinization, effectively prevents the recurrence of psoriasis, and reduces the suffering of patients.

A system for monitoring hemodynamic effectiveness includes a lead assembly including a lead body configured to deliver electrical stimulation or to deliver a fluid. The system includes at least one stimulation source including a drug pump or a pulse generator, a sensing device configured to detect a hemodynamic property of a body part, and a processor configured to determine hemodynamic effectiveness based on the detected hemodynamic property. Hemodynamic properties may include vasodilation, vasoconstriction, increased blood flow, decreased blood flow, or other hemodynamic changes. A method for providing treatment includes positioning a lead body adjacent to a blood vessel, obtaining a baseline hemodynamic property, administering stimulation, detecting an updated hemodynamic property, and determining hemodynamic effectiveness based on a change between the baseline and updated hemodynamic properties. A closed-loop treatment system adjusts treatment values based on measurements detected by the sensing device to cause stimulation to reach target values.

A system for treating erectile dysfunction in a male person is disclosed. The system comprises a stimulation device configured to deliver, directly or indirectly: a first stimulation signal to a sympathetic nerve innervating a penile vein of the person; and a second stimulation signal to a parasympathetic nerve innervating a penile artery of the person. The system further comprises a control unit configured to control an operation of the stimulation device such that: the first stimulation signal stimulates an activity of the sympathetic nerve, thereby causing vasoconstriction of the penile vein; and the second stimulation signal stimulates an activity of the parasympathetic nerve, thereby causing vasodilation of the penile artery. The vasodilation of the penile artery increases a blood flow entering an erectile body of the penis and the vasoconstriction of the penile vein reduces a blood flow exiting the erectile body, thereby inducing engorgement of the erectile body.

The present invention provides a vasospasm inhibitor and an oral composition for inhibiting vasospasm that can suppress abnormal vasoconstriction (vasospasm). [Solution] A vasospasm inhibitor and an oral composition for inhibiting vasospasm, containing as an active ingredient at least one compound selected from the group consisting of 2,5-dihydroxybenzoic acid, trans-3-caffeoylquinic acid, trans-4-caffeoylquinic acid, trans-5-caffeoylquinic acid, and 2-hydroxybenzoic acid, or a salt thereof.

A method for treating a skin lesion can include lowering a temperature of a treatment site to a temperature range sufficient to induce vasoconstriction in a dermis of the treatment site and administering a laser light through a medium to the skin lesion while maintaining the temperature of the treatment site within the temperature range. The medium can include a first portion and a second portion, where the laser light is transmitted through the first portion and the second portion sequentially, the second portion includes a contact surface for contacting the treatment site, and the second portion has a higher thermal conductivity than the first portion. The method can further include identifying the skin lesion and analyzing one or more characteristics of the skin lesion.

The present invention relates to a vasoconstriction-inhibiting factor (VIF) or a nucleic acid encoding it for the prevention and / or treatment of consequences of a heart disease. Furthermore, the present invention relates to pharmaceutical compositions containing the VIF and targeted (combination) therapies, in particular using the pharmaceutical compositions according to the invention. The present invention further relates to a kit for non-therapeutic in-vitro use containing the VIF or a nucleic acid encoding it.

This application discloses a precise active peptide of hemoglobin with the functions of replenishing qi and blood, improving microcirculation, and promoting vasodilation, as well as its preparation method and application, belonging to the field of hemoglobin peptide technology. The precise active peptide of hemoglobin contains at least one of LGFP, IGFP, FPHFN, LFL, LFI, FESF, ILF, LIF, FLL, FIL, FII, or FPHFD. The prepared precise active peptide of hemoglobin exhibits multiple biological activities: it exerts a hypotensive effect by inhibiting ACE and vasoconstrictive substances; it promotes vasodilation by activating the PI3K / AKT / eNOS signaling pathway; and it has been shown to significantly improve microcirculation and replenish qi and blood in a zebrafish model. The preparation method has low equipment requirements, is simple and easy to operate, and is suitable for large-scale industrial production. This invention enriches the bioactive peptide library and is of great significance for promoting technological progress and industrial upgrading in the field of hemoglobin peptides.

The present invention provides a scalp cooling device, including a covering part for wrapping a patient's scalp and a cooling part disposed within the covering part. This device can wrap around the patient's scalp and provide a cooling effect, causing the blood vessels in the scalp skin to constrict, reducing the blood flow to the scalp hair follicles, thereby reducing the intake of chemotherapeutic drugs by the hair follicles. Additionally, it lowers biochemical activity, thereby reducing the sensitivity of hair follicles to chemotherapy damage, and reduces the metabolic rate of the hair follicles, thus protecting the patient's hair follicles and preventing or mitigating hair loss caused by chemotherapy. Notably, the cooling part includes a gel-like coolant, which contains a moisture moderator and edible propylene glycol that maintains moisture and provides emulsifying and stabilizing effects, thus offering a long-lasting and stable cooling effect, enhancing the device's effectiveness in preventing hair loss.

The present disclosure relates to a topical aerosol deodorant composition that contains water, an organic solvent, an alpha-hydroxycarboxylic acid, one or more skin conditioning agents, optionally one or more hydrocarbon carrier agents, optionally caffeine or a xanthine derivative that has vasoconstrictive effects and a propellant. The topical aerosol deodorant composition may be sprayed onto a human's external skin in need or odor control such as the user's axilla, pudendum, feet, chest, abdomen, thigh, groin, pelvis and buttock without irritation.

This invention belongs to the field of pharmaceutical technology, specifically relating to the application of an MHC lactation modifier in the preparation of drugs for diseases related to promoting the body's lactation level. Specifically, it relates to the application of an MHC lactation modifier in the preparation of drugs for diseases related to promoting the body's lactation level, and the application of an MHC lactation modifier in the preparation of drugs for heart failure. The heart failure is defined as heart failure caused by decreased α-MHC-K1897 lactation due to Ang II-induced vasoconstriction. The invention also relates to the application of the aforementioned MHC lactation modifier in the preparation of drugs for heart failure caused by Ang II-induced vasoconstriction in humans, mice, or dogs. This invention also discovers new uses for p300 activators and SIRT1 inhibitors. Experimental studies have shown that treatment with p300 activators and SIRT1 inhibitors can affect the level of Myh6-K1897 lactation in the treatment of heart failure. The modification of Myh6-K1897 lactation as a therapeutic target plays an important role in the treatment of heart failure, providing a new approach to the treatment of heart failure.

The present invention provides a vasospasm inhibitor and an oral composition for inhibiting vasospasm that can suppress abnormal vasoconstriction (vasospasm). [Solution] A vasospasm inhibitor and an oral composition for inhibiting vasospasm, containing as an active ingredient at least one compound selected from the group consisting of 2,5-dihydroxybenzoic acid, trans-3-caffeoylquinic acid, trans-4-caffeoylquinic acid, trans-5-caffeoylquinic acid, and 2-hydroxybenzoic acid, or a salt thereof.

The microcatheter is provided with a vasospasm-inducing probe at its distal end. The spasm-inducing probe may include current, radio frequency energy, ultrasound, chemicals, or thermal regulators. When the spasm-inducing probe is activated in a blood vessel, the blood vessel narrows around the element. This allows the therapeutic agent to be delivered through the infusion lumen and out of the orifice at high pressure while the blood vessel narrowing functions as a pseudo-valve and prevents the therapeutic agent from reflowing after the blood vessel narrowing.

The invention discloses targeted prebiotic plant extraction dietary powder for conditioning hypertension and a preparation method thereof. According to the present invention, the lactobacillus plantarum CECT5716, the bifidobacterium lactis BLa80 and other strains selected in the formula can regulate the renin-angiotensin system balance by inhibiting the activity of the angiotensin converting enzyme so as to reduce the vasosystolic pressure from the neuroendocrine level; hawthorn flavone and pueraria isoflavone directly act on blood vessels to expand peripheral arteries, improve coronary artery blood flow and enhance blood vessel elasticity; the gamma-aminobutyric acid serving as a neurotransmitter can relieve sympathetic nerve hyperexcitation and reduce blood pressure fluctuation caused by emotion or pressure. Meanwhile, prebiotics such as resistant dextrin provide nutrients for probiotics, promote generation of intestinal short-chain fatty acids, activate a vascular endothelium protection pathway through an intestinal-metabolic axis, form a triple antihypertensive network of strain regulation, plant intervention and flora synergy, and cover different pathological links of blood pressure rise.

This invention discloses a traditional Chinese medicine composition for assisting in the improvement of hand-foot-mouth disease in infants and young children, belonging to the field of traditional Chinese medicine technology. The composition consists of eight medicinal herbs: lotus leaf, coix seed, angelica dahurica, kudzu root, platycodon root, agastache rugosa, cimicifuga rhizome, and dandelion, with a defined optimal medicinal ratio. Based on the seasonal differences in the pathogenesis of hand-foot-mouth disease, this invention targets the core pathologies of winter (cold congestion of microvessels, water and sodium retention, and internal heat generation) and spring and summer (hypothalamic sympathetic activation, increased heart rate, and visceral heat overload). It also addresses the technical deficiencies of clinical Western medicine, cold-natured traditional Chinese medicine, calamine lotion, and diuretics, such as vasoconstriction, kidney damage, central nervous system disorders, increased skin exudation, and rebound water retention. This invention employs a combination of warming and cooling herbs, regulating the ascending and descending functions, and promoting diuresis and protecting the body's vital energy. The synergistic effects of these herbs can dilate spasmodic microvessels, improve renal perfusion, stabilize abnormal heart rates, stabilize the hypothalamic center, and assist in antagonizing enteroviruses. By targeting and reducing abnormal permeability of skin capillaries with Angelica dahurica and Platycodon grandiflorus, it reduces blood extravasation and inhibits the formation and exudation of herpes from the root cause. This invention has mild medicinal properties, is suitable for all seasons, and has high safety. It can effectively improve symptoms of hand-foot-mouth disease such as fever, herpes, irritability, and cold extremities, reduce the risk of severe illness, antagonize the toxic side effects of commonly used clinical drugs, and is suitable for the delicate constitution of infants and young children, possessing good prospects for clinical application and promotion.

The invention relates to the technical field of femoral artery puncture surgical instruments, and discloses a femoral artery puncture port intelligent induction automatic protector which comprises a limiting mechanism, an angle adjusting mechanism, an angle fixing mechanism, a pressing mechanism, a pressing auxiliary mechanism and a ventilation mechanism. The angle adjusting mechanism is used for adjusting the pressing position according to the position and angle of the femoral artery, and the angle fixing mechanism is used for fixing the adjusted pressing angle, is in linkage with the pressing mechanism and can adjust the angle and position of the pressing auxiliary mechanism in the process that the pressing auxiliary mechanism gradually approaches a femoral artery puncture opening. The pressing assisting mechanism is used for accelerating wound healing and meanwhile enabling blood vessels to contract, the ventilation mechanism is used for keeping ventilation in the protector shell, bacteria breeding caused by human body sweating is prevented, and the femoral artery puncture opening is pressed and assisted in rapid healing of the femoral artery puncture opening.

The invention provides a non-inductive blood pressure continuous monitoring method and device based on single calibration and a storage medium, and the method comprises the steps: in an equipment calibration stage, in a measurement period of a pressurized sphygmomanometer, obtaining a human body monitoring signal; calculating periodic intensities of signals at different monitoring distance units based on the human body monitoring signals, and determining a target monitoring position; continuously acquiring human body monitoring signals corresponding to the target monitoring position, extracting phase change signals from the human body monitoring signals, further extracting pulse wave signals, and inputting the signals into a blood vessel feature extraction network to obtain blood vessel feature parameters; in the independent monitoring stage, continuously acquiring a human body monitoring signal corresponding to the target monitoring position; and segmenting the human body monitoring signal of the target monitoring position into multiple groups of signal segments in parallel, and inputting the signal segments and the blood vessel characteristic parameters into a pre-trained blood pressure prediction model to obtain a time sequence prediction result representing the systolic pressure and the diastolic pressure of the blood vessel. According to the invention, nighttime non-inductive blood pressure measurement can be realized, and meanwhile, the accuracy and robustness of nighttime blood pressure continuous tracking are improved.

This invention discloses a post-medical aesthetic repair and soothing composition, its preparation method, and its application, relating to the field of cosmetic technology. The invention provides a repair and soothing composition comprising the following components in parts by weight: 0.1-1 parts citrus fruit extract, 0.1-0.5 parts date palm fruit extract, 0.05-0.5 parts gentian root extract, and 0.1-1 parts liposomes; wherein the liposomes comprise dipotassium glycyrrhizate and phytol. The repair and soothing composition provided by this invention achieves rapid repair and long-term stabilization through a multi-dimensional synergistic mechanism. The above-mentioned composition of this invention synergistically regulates skin pH, instantly blocks the transmission of neurogenic pain signals mediated by TRPV1 receptors, synergistically rebuilds the physical and microecological barriers, promotes vasoconstriction, and activates skin TRPM cold receptors, achieving the effect of a "cold compress."

A denervation system and method uses vasoconstriction response to stimulation to intraoperatively guide an interventional physician to understand therapy effectiveness. The denervation system and method involve receiving a first radiographic image of a blood vessel, receiving a second radiographic image of the blood vessel after treating and stimulating a target blood vessel site, and determining a first vasoconstriction metric based on the first radiographic image and the second radiographic image. The denervation system and method also involve receiving a third radiographic image and a fourth radiographic image of the blood vessel before and after stimulation of the target vascular site, respectively, prior to treating the target vascular site, and determining a second vasoconstriction metric based on the third radiographic image and the fourth radiographic image. The denervation system and method also involve outputting an indication of whether the treatment is complete based on the first vasoconstriction metric and / or the second vasoconstriction metric.

The invention discloses a novel application with a cold compress hemostasis function for hemodialysis, and relates to the technical field of medical supplies. The plaster comprises a plaster body, a first opening is formed in the plaster body, internal threads are formed in the upper side of the plaster body and located in the first opening and the inner wall of a mounting head, and bandages used for binding are arranged on the two sides of the plaster body; the hydrocolloid dressing layer is attached to the lower side of the application body. The hydrocolloid dressing layer can be directly and firmly adhered to the skin at the edge of a wound and can absorb seepage, the pressing cylinder is arranged and moves downwards by rotating the pressing cylinder so as to slowly press and stop bleeding of the wound, and the cold insulation ring is arranged so that local blood vessels around the wound can be conveniently constricted. And the traditional Chinese medicine preparation can be immediately used after dialysis, so that the wound can be scientifically nursed, and the pain of a patient can be relieved.

The invention discloses a wearable intelligent clothing management system convenient for temperature adjustment. According to the invention, a physiologically-driven active temperature control mode is realized through the biological rhythm prediction engine, and the comfort level and health management level of a human body are remarkably improved. The system constructs a unique body temperature regulation curve model based on continuously monitored personal biological rhythm data, and can pre-judge body temperature demand changes of a user during scene switching from a static scene to a moving scene, from an indoor scene to an outdoor scene and the like in advance. Mild heating is automatically started in the morning metabolic rate rising stage, and vasoconstriction caused by sudden body temperature drop after getting up is prevented; or when afternoon cortisol secretion is reduced, local refrigeration is enhanced in advance, and body temperature imbalance caused by drowsiness is avoided. In combination with an emotional state recognition function, the system can dynamically adjust a collaborative strategy of the phase-change material and the air duct system aiming at abnormal perspiration or cold vibration caused by psychological fluctuations such as pressure and excitement, and body temperature optimization in physical and mental dimensions is realized.

The present disclosure relates to a topical aerosol deodorant composition that contains water, an organic solvent, an alpha-hydroxycarboxylic acid, one or more skin conditioning agents, optionally one or more hydrocarbon carrier agents, optionally caffeine or a xanthine derivative that has vasoconstrictive effects and a propellant. The topical aerosol deodorant composition may be sprayed onto a human's external skin in need or odor control such as the user's axilla, pudendum, feet, chest, abdomen, thigh, groin, pelvis and buttock without irritation.

The present disclosure relates to compositions and methods for treating dry eye caused by, for example, tear film deficiency in the eye, by applying to the eye or surrounding area an oil-in-water emulsion composition comprising brimonidine, and optionally comprising a demulcent, e.g., a hyaluronic acid compound, in combination with inducing vasoconstriction to treat ocular conditions such as red eye (conjunctival hyperemia).

To provide a head compression cap capable of reducing loss of hair by an adverse effect of an anti-cancer drug more by compressing the superficial temporal artery and the occipital artery of a user's head to suppress a blood flow and cooling the scalp of the user.SOLUTION: In the head compression cap, a temple pressing part compresses a user's superficial temporal artery moderately and an occipital pressing part compresses the occipital artery moderately. The arteries are thereby narrowed physically and the blood flow is reduced. In this state, a cooling part cools the scalp of the user. The blood vessel of the scalp is thereby contracted, and the blood flow to hair-mother cells is further reduced, and the metabolic activity of the hair-mother cells is suppressed. When administration of an anti-cancer drug is received in this state, an adverse effect of the anti-cancer drug on hair-mother cells and hair roots can be reduced. Loss of hair of the head, which is an adverse effect of the anti-cancer drug, can be thereby prevented or reduced further, and even when loss of hair occurs, hair growth can be accelerated more than ever before. When hair is growing, the original hair quality and quantity can be maintained.SELECTED DRAWING: Figure 1

The utility model relates to the technical field of rehabilitation medical instruments, and discloses a three-section type pressurizable ice compress sleeve which comprises an ice compress sleeve body, a pressurizing sleeve is arranged on the ice compress sleeve body, the pressurizing sleeve body wraps the outer ring of the ice compress sleeve body and then is overlaid and pasted to form an adjustable enclosure structure, and a rubber ball is arranged at the air inlet end of the pressurizing sleeve body. An adjusting chock plug is arranged at the air outlet end of the pressurizing sleeve, and the adjusting chock plug is communicated with the pressurizing sleeve for deflation after moving and translating in the horizontal direction. The ice compress sleeve with the pressurization adjusting structure is formed in a double-layer combined wearing mode, the action side of an ice bag can be adjusted according to treatment requirements in a detachable mode, damage to the skin is relieved, tolerance is improved, the limb end is wrapped in a pressurization mode, vasoconstriction is stimulated, and the treatment effect is improved. Meanwhile, the situation that the ice compress effect is affected due to the fact that gaps exist between the ice bag and the limb end due to the ice bag contour and the melting degree is reduced, and the three-section structure is matched so that the wearing comfort and the fitting degree of the ice compress sleeve can be improved.

The present invention relates to an umbilical cord blood-derived vascular endothelial progenitor cell and a composition for preventing or treating ischemic diseases comprising the same, and more specifically, to an umbilical cord blood-derived vascular endothelial progenitor cell and a composition for preventing or treating ischemic diseases, the present invention relates to a high-purity umbilical cord blood-derived vascular endothelial progenitor cell exhibiting specific surface antigen characteristics, a method for obtaining an umbilical cord blood-derived vascular endothelial progenitor cell by pre-treating umbilical cord blood, and a composition for preventing and treating ischemic diseases comprising the umbilical cord blood-derived vascular endothelial progenitor cell. The high-purity umbilical cord blood-derived vascular endothelial progenitor cell of the present invention exhibits colony formation, high proliferation ability, and high potential for angiogenesis in vivo, and thus can exhibit an excellent effect on the prevention or treatment of various ischemic diseases induced by blood vessel contraction or occlusion.

This invention discloses a finger systolic blood pressure measuring device and method. The device uses a finger sleeve to stably receive liquid pressure from a liquid delivery module, precisely compressing the finger's blood vessels. A strain gauge at the distal end sensitively captures blood flow recovery pulsation data, providing a reliable basis for systolic blood pressure calculation. A temperature control module maintains a suitable liquid temperature, reducing the impact of temperature on measurement results and improving measurement accuracy and stability. This ensures consistent performance under different ambient temperatures, enhancing applicability and reliability. The liquid delivery module automatically adjusts the water pressure, precisely controlling blood vessel compression and relaxation, simplifying manual operation and improving measurement efficiency and accuracy. A data processing module automatically collects and processes data, quickly calculating systolic blood pressure, reducing human error and increasing measurement speed.

Method for contactless blood pressure monitoring of a patient (100), wherein the method comprises: Irradiation (202) of a patient's (100) blood vessel with infrared light, IR light through a blood pressure control system; Receiving (204) IR light reflected by the patient (100) via a polarization filter (108) through an IR camera (104) of the blood pressure monitoring system; Capturing (206), at a time based on a patient's heart rate (100), an initial IR image (208) of the patient's blood vessel (100) by the IR camera (204) of the blood pressure control system when the blood vessel is dilated; Determining (210) a maximum diameter of the blood vessel from the first image (208) by the blood pressure control system; Capturing (212), at a time based on the patient's heart rate (100), a second IR image (214) of the patient's blood vessel by the IR camera (104) of the non-contact blood pressure monitoring system when the blood vessel is constricted; Determining (216) a minimum diameter of the blood vessel from the second IR image (214) by the blood pressure control system; and Calculating (224) the patient's blood pressure as a function of the maximum and minimum diameters (218, 220) of the blood vessel by the blood pressure control system, where the calculation (224) of the patient's blood pressure further includes a reduction (702) of the influence of background radiation by a source separation algorithm.

Provided are thermo-responsive nitric oxide (NO) releasing molecules ("donors") and their use with polymer delivery systems. The delivery systems may include devices that allow for delivery of a dose of NO for inhalation such as portable inhalation devices. The compositions and methods may be used in the treatment of pulmonary conditions such as pulmonary hypertension, acute pulmonary vasoconstriction, respiratory distress syndrome, pulmonary edema, sepsis, and asthma. In some aspects, the compositions and methods provide a portable NO delivery mechanism allowing safe and pure NO administration outside of as well as in hospital settings.